Lack of correlation between hepatic prostaglandin concentrations and DNA synthesis after the administration of phenobarbital and the peroxisome proliferator ciprofibrate in rats

Toxicology

Volumn 123, Issue 1-2, 1997, Pages 101-109

  Leung, Lai K ^a,b   Glauert, Howard P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Ciprofibrate; Eicosanoids; Peroxisome; Phenobarbital; Prostaglandins

Indexed keywords

ACYL COENZYME A OXIDASE; CIPROFIBRATE; CYTOCHROME P450 ISOENZYME; ICOSANOID; PEROXISOME PROLIFERATOR; PHENOBARBITAL; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; LIVER CARCINOGENESIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ACYL-COA OXIDASE; ANIMALS; CARCINOGENS; CLOFIBRIC ACID; CYTOCHROME P-450 CYP2B1; DINOPROST; DINOPROSTONE; DNA; LIVER; MALE; MICROBODIES; MICROSOMES, LIVER; OXIDOREDUCTASES; PHENOBARBITAL; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RODENTIA;

EID: 0030801911     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(97)00110-8     Document Type: Article

References (35)

1. Akerman, P., Cote, P., Yang, S.Q., McClain, C., Nelson, S., Bagby, G.J., Diehl, A.M., 1992. Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 263, G579-G585.
2. 2α. J. Lipid Res. 31, 1477-1482.
3. Beg, A., Sha, W.C., Bronson, R.T., Ghosh, S., Baltimore, D., 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170.
4. Bojes, H.K., Thurman, R.G., 1996. Peroxisome proliferators activate Kupffer cells in vivo. Cancer Res. 56, 1-4.
5. Bojes, H.K., Germolec, D.R., Simeonova, P., Schoonhoven, R., Luster, M.I., Thurman, R.G., 1996. Peroxisome proliferators (PP) activate the production of mitogens by Kupffer cells in vivo: studies with antibodies to TNFα. Toxicologist 30, 207.
6. Brass, E.P., Ruff, L.J., 1991. Effect of clofibrate treatment on hepatic prostaglandin catabolism and action. J. Pharmacol. Exp. Ther. 257, 1034-1038.
7. 2 action in rat hepatocytes by inhibitors of oxidative metabolism. Biochem. Pharmacol. 37, 1343-1349.
8. Burke, M.D., Thompson, S., Elcombe, C.R., Halpert, J., Haaparanta, T., Mayer, R.T., 1985. Ethoxy-, pentoxy- and benzyloxy-phenoxanes and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34, 3337-3345.
9. 2 production is amplified during hepatic regeneration. Hepatology 14, 368-372.
10. Chen, H., Huang, C.Y., Wilson, M.W., Lay, L.T., Robertson, L.W., Chow, C.K., Glauert, H.P., 1994. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats. Carcinogenesis 15, 2847-2850.
11. Denda, A., Ura, H., Tsujiuchi, T., Tsutsumi, M., Eimoto, H., Takashima, Y., Kitazawa, S., Kinugasa, T., Konishi, Y., 1989. Possible involvement of arachidonic acid metabolism in phenobarbital promotion of hepatocarcinogenesis. Carcinogenesis 10, 1929-1935.
12. Denda, A., Tang, Q., Endoh, T., Tsujiuchi, T., Horiguchi, K., Noguchi, O., Mizumoto, Y., Nakae, D., Konishi, Y., 1994. Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient L-amino acid-defined diet in rats. Carcinogenesis 15, 1279-1283.
13. Gill, J.L., 1978. Design and Analysis of Experiments in the Animal and Medical Sciences, vol. 1. Iowa State University Press, Ames, Iowa.
14. 2 in the liver of rats fed a choline deficient diet: possible involvement in liver tumor promotion. Cancer Lett. 46, 129-135.
15. 2α, glutathione-S-transferase activity, and oxidative stress. Prostaglandins Leukotrienes Essential Fatty Acids 42, 45-50.
16. Hong, J.T., Glauert, H.P., 1996. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes. J. Cell. Physiol. 169, 309-319.
17. Kaufmann, W.K., Paules, R.S., 1996. DNA damage and cell cycle checkpoints. FASEB J. 10, 238-247.
18. 2. Biochem. Biophys. Res. Commun. 137, 404-410.
19. Laskin, D.L., Robertson, F.M., Pilaro, A.M., Laskin, J.D., 1988. Activation of liver macrophages following phenobarbital treatment of rats. Hepatology 8, 1051-1055.
20. Lee, S.S.-T., Pineau, T., Drago, J., Lee, E.J., Owens, J.W., Kroetz, D.L., Fernandez-Salguero, P.M., Westphal, H., Gonzalez, F.J., 1995. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15, 3012-3022.
21. Leung, L.K., Glauert, H.P., 1996a. Induction of cyclooxygenase-II by the peroxisome proliferator ciprofibrate in rats. FASEB J. 10, A146.
22. 2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate. Toxicol. Lett. 85, 143-149.
23. Li, Y., Leung, L.K., Glauert, H.P., Spear, B.T., 1996. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-κB activity. Carcinogenesis 17, 2305-2309.
24. MacManus, J.P., Braceland, M., 1976. A connection between the production of prostaglandins during liver regeneration and the DNA synthetic response. Prostaglandins 11, 609-620.
25. Peebles, R.S., 1996. The effect of phenobarbital on the hepatic concentrations of eicosanoids. M.S. Thesis, University of Kentucky, Lexington, KY.
26. Poosch, M.S., Yamazaki, R.K., 1986. Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay. Biochim. Biophys. Acta 884, 585-593.
27. Reddy, J.K., Lalwani, N.D., 1983. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol. 12, 1-58.
28. 2α-additivity with the effect of norepinephrine, and synergism with epidermal growth factor. J. Cell. Physiol. 159, 35-40.
29. Satoh, M., Yamazaki, M., 1992. Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor β and interleukin 6. J. Cell. Physiol. 150, 134-139.
30. Satoh, M., Adachi, K., Suda, T., Yamazaki, M., Mizuno, D., 1991. TNF-driven inflammation during mouse liver regeneration after partial hepatectomy and its role in growth regulation of liver. Mol. Biother. 3, 136-147.
31. Schwarz, M., Buchmann, A., Robertson, L.W., Kunz, W., 1990. Cell proliferation and hepatocarcinogenesis. In: S.H. Moolgavkar (Ed.), Scientific Issues in Quantitative Cancer Risk Assessment. Birkhäuser, Boston, pp. 96-115.
32. Skouteris, G.G., Ord, M.G., Stocken, L.A., 1988. Regulation of the proliferation of primary rat hepatocytes by eicosanoids. J. Cell. Physiol. 135, 516-520.
33. Tang, Q., Denda, A., Tsujiuchi, T., Tsutsumi, M., Amanuma, T., Murata, Y., Maruyama, H., Konishi, Y., 1993. Inhibitory effects of inhibitors of arachidonic acid metabolism on the evolution of rat liver preneoplastic foci into nodules and hepatocellular carcinomas with or without phenobarbital exposure. Jpn. J. Cancer Res. 84, 120-127.
34. Tsuruta, S., Nakata, K., Ohata, N., Gondo, Y., Sato, Y., Nakayama, T., Nakao, K., Shima, M., Ishii, N., 1992. Enhanced DNA synthesis in rat hepatoma cells by conditioned media from Kupffer cells incubated with supernatants of tumor necrosis factor-α pretreated hepatocytes. Biochem. Biophys. Res. Commun. 183, 1147-1152.
35. Wilson, M.W., Lay, L.T., Chow, C.K., Tai, H.-H., Robertson, L.W., Glauert, H.P., 1995. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Arch. Toxicol. 69, 491-497.